Brief: Iconovo Receives Additional Development Contract From Kiox Pharma
17/08/2023 07:27
Aug 17 (Reuters) - Iconovo AB ICO.ST :
* ICONOVO RECEIVES ADDITIONAL DEVELOPMENT CONTRACT FROM KIOX
PHARMA FOR NEW INHALABLE TREATMENT AGAINST RARE DISEASE
* AGREEMENT ENTAILS REVENUES OF SEK 1.1 MILLION FOR ICONOVO
Source text for Eikon: ID:nMFN3nlsJb
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))